Arbutus Biopharma Corpora...

3.53
0.05 (1.44%)
At close: Apr 02, 2025, 3:59 PM
3.36
-4.71%
After-hours: Apr 02, 2025, 07:55 PM EDT

Arbutus Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007 Dec 31, 2006 Dec 31, 2005 Dec 31, 2004 Dec 31, 2003 Dec 31, 2002 Dec 31, 2001 Dec 31, 2000 Dec 31, 1999 Dec 31, 1998
Cash & Equivalents 36.33M 26.29M 30.78M 109.28M 52.25M 31.8M 36.9M 54.3M 23.4M 166.78M 72.2M 68.72M 47.03M 9M 12.34M 23.3M 21.54M 21.13M 4.87M 10.48M 24.99M 35.56M 20.5M 25.63M 2.05M 10.91M 797.59K
Short-Term Investments 86.29M 99.72M 116.14M 46.03M 71.02M 59.03M 87.7M 72.1M 107.1M 14.53M 40M n/a n/a n/a n/a n/a 4.71M n/a n/a n/a n/a 3.65M 17.67M 21.93M 21.93M 8.71M 5.66M
Long-Term Investments n/a 6.28M 37.36M 35.69M n/a n/a 22.2M 12.6M 12.6M 10.07M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 575.15K 1.54M 2.13M 2.2M 166.72K 172.61K 162.47K
Other Long-Term Assets 34K n/a 103K 61K 44K 293K 22.22M 12.6M 12.6M n/a n/a n/a n/a n/a n/a n/a 1.00 n/a n/a n/a 1.16M 228.51K 1.00 15.04M 4.86M 5.7M 6M
Receivables 2.41M 1.78M 1.35M 899K 1.31M 1.2M 1.43M 870K 694K 1.38M 2.53M 329K 3.46M 1.19M 3.75M 1.27M 839.93K 1.84M 604.55K 259.96K 1.8M 390.25K 520.38K 2M 801.06K 532.01K 212.38K
Inventory n/a n/a -2.87M -4.45M -3.12M n/a n/a n/a 1.00 1.07M n/a 1.04M -2.04M 1.00 150.71K n/a 143.41K 215.1K 1.00 2.00 277.31K n/a 1.00 1.00 208.31K 1.00 1.00
Other Current Assets 2.28M 4.25M 2.87M 4.45M 3.12M 1.79M n/a 340K 293K n/a 86K 213K 431.41K 771.9K 1.14M 0.00 81.3K 110.22K 65.25K 180.09K 1.66M 500.87K 0.00 0.00 0.00 0.00 148.23K
Total Current Assets 127.32M 132.03M 151.14M 160.66M 127.7M 93.83M 129.2M 129.4M 132.6M 183.88M 116.4M 70.34M 51.25M 11.55M 17.91M 24.79M 27.33M 23.29M 5.53M 10.92M 28.73M 40.1M 38.89M 49.78M 25.23M 20.22M 6.82M
Property-Plant & Equipment 4.36M 6.09M 6.81M 8.07M 9.33M 11.41M 10.2M 12.2M 6.9M 3.18M 1.8M 1.37M 1.35M 2.15M 3.11M 2.69M 2.14M 1.54M 499.75K 953.31K 3.43M 4.1M 3.74M 2.79M 2.43M 2.88M 3.02M
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a 66.3M 83M 123.8M 515.16M n/a n/a n/a n/a n/a 14.47M 12.87M n/a n/a 6.62M 7.19M 4.76M 8.45M 12.83M 4.69M 5.53M 5.84M
Total Long-Term Assets 4.39M 12.37M 44.28M 43.82M 9.38M 11.71M 98.7M 107.8M 143.3M 528.41M 1.8M 1.37M 1.35M 2.15M 3.11M 17.16M 15.01M 1.54M 499.75K 7.57M 12.36M 10.63M 14.32M 17.83M 7.29M 8.58M 9.02M
Total Assets 131.71M 144.4M 195.42M 204.49M 137.08M 105.53M 227.9M 237.2M 275.9M 712.29M 118.2M 71.72M 52.6M 13.7M 21.02M 41.95M 42.34M 24.83M 6.03M 18.5M 41.1M 50.73M 53.22M 67.6M 32.52M 28.8M 15.83M
Account Payables 2.32M 3.22M 3.52M 3.17M 2.99M 2.4M 3.19M 1.99M 3.21M 2.61M 2.04M 1.22M 805.79K 1.26M n/a 2M 509.38K 313.56K 314.59K 1.29M 933.44K n/a n/a n/a n/a n/a n/a
Deferred Revenue 7.57M 11.79M 16.46M 7.64M 5.91M 4.84M n/a 2.74M 15K 868K 5.78M 3.46M 3.14M 2.75M 1.98M 1.11M 377.23K 4.65M -0.00 373.51K n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt 483K n/a 372K 383K 390K 340K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 76.43K n/a n/a 686.63K 282.17K n/a n/a n/a n/a n/a
Other Current Liabilities 5.25M 3.7M 16.81M -383K -140K -87K 5.71M 7M 5.18M 4.77M 9.51M 8.86M 4.06M 211.36K 6.15M 2.00 232.81K -76.43K 1.31M 121.18K 9.18M 4.12M 4.66M 2.47M 1.85M 1.29M 830.41K
Total Current Liabilities 15.62M 22.49M 32.86M 11.22M 9.54M 7.83M 10M 11.9M 10.6M 10.58M 14.4M 12.52M 10.96M 6.84M 8.13M 6.51M 4.05M 6.46M 5.81M 2.21M 10.88M 4.53M 4.8M 2.58M 1.91M 1.32M 830.41K
Long-Term Debt 806K 6.95M n/a n/a n/a n/a n/a 12M 12M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 869.45K 602.34K n/a n/a n/a n/a n/a
Other Long-Term Liabilities 17.92M 7.6M 17.9M 21.59M 22.98M 2.95M 3.77M 28.06M 50.33M 7.5M n/a n/a n/a n/a n/a n/a n/a n/a n/a 34.69M 32.27M 2.01M 2.58M 2.65M 515.75K 533.82K 574.53K
Total Long-Term Liabilities 18.72M 15.9M 25.71M 23.82M 25.57M 24.96M 17.7M 42.8M 62.3M 154.03M 15.8M n/a 722.51K 1.66M 2.16M n/a n/a n/a 64.97K 34.78M 40.71M 2.81M 3.07M 3.53M 589.69K 597.25K 574.53K
Total Liabilities 34.34M 38.38M 58.57M 35.05M 35.11M 32.79M 27.7M 54.7M 72.9M 164.61M 30.2M 12.52M 11.68M 8.5M 10.29M 6.51M 4.05M 6.46M 5.88M 36.99M 51.6M 7.35M 7.87M 6.12M 2.49M 1.92M 1.4M
Total Debt 1.29M 8.72M 2.19M 2.61M 2.98M 3.36M n/a 12M 12M n/a n/a n/a n/a n/a n/a n/a n/a 76.43K 148.06K 135.09K 1.78M 1.22M 302.81K 355.46K 128.53K 97.77K n/a
Common Stock n/a 1.35B 1.32B 1.29B 985.94M 898.53M 879.4M 876.11M 867.39M 834.24M 290M 216.7M 239.48M 10.33B 10.33B n/a n/a 197.23M 154.63M 155.19M 149.93M 138.11M 96.08M 94.76M 68.21M 56.88M 34.98M
Retained Earnings n/a -1.28B -1.2B -1.13B -1.05B -970.09M -805.22M -738.07M -651.15M -266.99M -205.86M -167.03M -230.25M -253.52M -248.87M -211.87M -174.27M -199.76M -167.53M -191.4M -177.12M -142.48M -79.61M -50.58M -38.18M -30M -20.55M
Comprehensive Income -48.13M -48.42M -50.49M -48.34M -48.17M -48.23M -48.17M -48.19M -49.78M -49.78M -22.31M -15.83M -13M -16.15M -15.55M -11.93M -11.58M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity 97.37M 106.02M 136.85M 169.44M 101.97M 72.74M 200.2M 182.5M 203M 547.68M 88M 59.19M 40.92M 5.21M 10.73M 35.44M 38.29M 18.37M 155.53K -18.49M -10.5M 43.38M 45.35M 61.49M 30.03M 26.88M 14.43M
Total Investments 86.29M 106M 153.5M 81.72M 71.02M 59.03M 109.9M 72.1M 107.1M 24.59M 40M n/a n/a n/a n/a n/a 4.71M n/a n/a n/a 575.15K 5.19M 19.8M 24.13M 22.09M 8.88M 5.82M